"The mechanistic basis of cancer immunotherapy" | 30 October 2024

During this Grand Rounds, experts discuss "The mechanistic basis of cancer immunotherapy"

Presenter:
Ira Mellman, PhD, Vice President of Cancer Immunology at Genentech

Learn more: medicine.stanford.edu/